Laboratory Corp of America Holdings LH
News
Labcorp Announces Winning Bid for Select Assets of Invitae
Invitae Enters into Agreement with Labcorp for Sale of Business
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Labcorp Declares Quarterly Dividend
Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp to Announce First Quarter Financial Results on April 25, 2024
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
Labcorp Launches Weight Loss Management Testing Solutions
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Labcorp Announces 2023 Fourth Quarter and Full Year Results
Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform